Bedi Varinder Singh, Swain Pranati, Yadav Ajay
Institute of Vascular & Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi, Delhi 110060 India.
Army Hospital R & R, New Delhi, Delhi 110010 India.
Indian J Thorac Cardiovasc Surg. 2019 Jun;35(Suppl 2):174-178. doi: 10.1007/s12055-019-00837-8. Epub 2019 May 30.
The standard of care in uncomplicated acute type B aortic dissection (uTBAD) has been optimal medical management. Surgical repair and endovascular interventions are adjuncts in managing complicated type B dissection. Increasing safety and confidence in the thoracic endovascular aortic repair (TEVAR) and recent data indicating long-term complications in medical management of uTBAD has brought a shift in treatment approach. TEVAR at best remains controversial, yet there is a subset, which will definitely benefit from intervention.
单纯急性B型主动脉夹层(uTBAD)的标准治疗方法一直是最佳药物治疗。手术修复和血管内介入是治疗复杂B型夹层的辅助手段。胸主动脉腔内修复术(TEVAR)的安全性不断提高且信心增强,以及近期数据表明uTBAD药物治疗存在长期并发症,这使得治疗方法发生了转变。TEVAR充其量仍存在争议,但有一部分患者肯定会从干预中获益。